1
![Adamas Pharmaceuticals]()
![Adamas Pharmaceuticals]()
![Adamas Pharmaceuticals]()
Adamas Pharmaceuticals
Leadership team
Gangadhara Ganapati (Founder)
Greg Went (Founder)
Products/ Services
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Number of Employees
50 - 100
Headquarters
Emeryville, California, United States
Established
2000
Company Registration
SEC CIK number: 0001328143
Traded as
NASDAQ:ADMS
Overview
Location
Summary
Adamas is a biopharmaceutical company focused on developing and commercializing therapeutics to improve the lives of those affected by chronic neurologic disorders.
History
Adamas was founded in 2007 by Srini Phadke and Rajiv Raisani. It has since become a specialty pharmaceutical company focused on addressing the unmet need in the treatment of chronic neurologic disorders through the development of novel therapeutics.
Mission
To develop innovative treatments and improve the lives of those affected by chronic neurologic disorders.
Vision
To be a global leader in the development and commercialization of treatments for chronic neurologic disorders.
Key Team
Gangadhara Ganapati (Founder)
Greg Went (Founder)
Recognition and Awards
Adamas has earned several awards and recognitions in the past, including being ranked in the Deloitte Fast 500 for Fastest Growing Companies in the United States and the Deloitte Technology Fast 50 for fastest growing healthcare companies in the Bay Area.
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Leadership team
Gangadhara Ganapati (Founder)
Greg Went (Founder)
Products/ Services
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Number of Employees
50 - 100
Headquarters
Emeryville, California, United States
Established
2000
Company Registration
SEC CIK number: 0001328143
Traded as
NASDAQ:ADMS